Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer.

ABSTRACT:

SUBMITTER: De Giglio A 

PROVIDER: S-EPMC9554691 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature